Novartis AG's Fiscal Year is From January To December.
The item "Debt-To-Equity-Ratio" stands at 0.6854 as of 09/30/2025.
As of the end of Novartis AG's third quarter, the item "Debt To Equity Ratio" stands at 0.6854. This represents a decrease of -7.31 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -2.86 percent compared to the value the year prior.
The 1 year change in percent is -2.86.
The 3 year change in percent is 54.18.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Debt To Equity Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Debt To Equity Ratio | 486,508,953,600.00 |
![]() | AbbVie Inc - Debt To Equity Ratio | 399,570,305,024.00 |
![]() | Roche Holding AG - Debt To Equity Ratio | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Debt To Equity Ratio | 280,205,508,085.11 |